Sudeep Pharma Limited has opened its initial public offering (IPO) today, November 21, 2025. Investors are closely watching the market debut, as the company looks to raise ₹895 crore through a combination of fresh issuance and an offer-for-sale (OFS).
Market Performance & IPO Overview
- IPO Price Band: ₹563 to ₹593 per share
- Total Issue Size: ₹895 crore
- Fresh Issue: ₹95 crore
- OFS: ₹800 crore
- Listing Venues: NSE and BSE
- Lot Size: 25 shares per lot
The IPO opened today and will remain available for subscription until November 25, 2025. The company has appointed MUFG Intime India as the official registrar for the issue.
Sudeep Pharma IPO Subscription Status
By 11:18 AM on day one:
- Overall Subscription: 0.39x
- Retail Portion: 0.52x
- Non-Institutional Investors (NII): 0.60x
These early figures reflect the initial interest in the IPO as investors evaluate the company’s growth story.
Important IPO Dates
- Allotment Date: 26 November 2025 (expected)
- Listing Date: 28 November 2025 (expected)
The IPO is structured to accommodate both retail and institutional investors, ensuring broad participation in the offering.
Company Snapshot: Sudeep Pharma
Sudeep Pharma operates as a key supplier of critical pharma-grade ingredients, catering to a roster of global customers across the pharmaceutical, food, nutrition, and speciality ingredients sectors.
Key highlights:
- Diverse Portfolio: Over 100 products across multiple markets
- Revenue & Profitability: Strong FY25 financial performance with rising revenues and high EBITDA margins
- Global Reach: Serving marquee clients internationally with a technology-driven manufacturing ecosystem
With its strong market positioning, Sudeep Pharma stands to gain as India’s food and nutritional ingredients sector expands at an 8.1% CAGR, growing from $22 billion in 2024 to $32 billion by 2029.
Financial Snapshot
- Revenue: Rising trend in FY25 compared to the previous fiscal year
- EBITDA Margins: Strong profitability metrics maintained
- Return on Net Worth (RONW): 27.88% in FY25
These numbers reflect a stable operational performance and a solid foundation for future growth.
Summary
Sudeep Pharma’s IPO launch marks a significant milestone for the company as it enters the Indian stock market. With a diversified portfolio, global clientele, and a robust financial track record, the IPO offers investors a transparent view of the company’s market position and growth trajectory.
Easy & quick
Leave A Comment?